We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Technology Provides Coronary Artery Calcification Scoring on Ungated Chest CT Scans

By MedImaging International staff writers
Posted on 31 Dec 2024
Image: The new technology adds coronary artery calcification scoring to ungated chest CT scans (Photo courtesy of Riverain Technologies)
Image: The new technology adds coronary artery calcification scoring to ungated chest CT scans (Photo courtesy of Riverain Technologies)

Coronary artery calcification (CAC) impacts 20 million Americans each year, with over half of incidental findings going unreported. Traditionally, coronary artery calcium scans were only available to symptomatic patients through specialized CT scans, missing the opportunity for early detection. Now, a new FDA-cleared technology provides a CAC score, helping to identify heart disease risk from any ungated, non-contrast chest CT scan.

Riverain Technologies (Miamisburg, OH, USA) offers the ClearRead CT CAC system, which accurately detects, quantifies, and reports the Agatston score. This system is compatible with ungated, non-contrast standard, and low-dose chest CT exams, making it an ideal addition to lung cancer screening programs. It also benefits patients undergoing CT scans for other conditions. Riverain’s FDA-cleared ClearRead software employs advanced machine learning and AI technologies to deliver consistent imaging results across various devices and patient groups.

The ClearRead solutions, incorporating Clear Visual Intelligence, utilize unique suppression technology to eliminate interfering structures, such as bones and vessels, and machine noise that can distort accurate diagnoses. This technology provides a clear, unobstructed view, allowing radiologists to focus on actionable data, improving diagnostic accuracy and enabling earlier intervention. By adding CAC scoring, the ClearRead CT suite enhances its existing nodule detection capabilities.

"With more than 4 million imaging exams now processed annually using ClearRead solutions, there is a huge opportunity to improve the health of patients by maximizing the findings in each scan," said Steve Worrell, CEO of Riverain Technologies. "ClearRead CT CAC enables healthcare providers to use ungated chest CT for early intervention and assessment of cardiac risk."

Related Links:
Riverain Technologies

Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
Pocket Fetal Doppler
CONTEC10C/CL
Ultrasound Needle Guidance System
SonoSite L25
New
X-Ray Generator
Advantage Plus Generators

Channels

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.